Early Childhood Neurodevelopmental Outcomes After Early Infant Invasive Group B Streptococcal Infection in Uganda - Summary - MDSpire

Early Childhood Neurodevelopmental Outcomes After Early Infant Invasive Group B Streptococcal Infection in Uganda

  • By

  • Samantha Sadoo

  • Carol Nanyunja

  • Mary Kyohere

  • Hannah G Davies

  • Valerie Tusubira

  • Cleophas Komugisha

  • Joseph Peacock

  • Margaret Sewegaba

  • Philippa Musoke

  • Musa Sekikubo

  • Kirsty Le Doare

  • Cally J Tann

  • PROGRESS Study Author Group

  • Abdelmajid Djennad

  • Agnes Nyamaizi

  • Agnes Ssali

  • Alexander Amone

  • Amusa Wamawobe

  • Annettee Nakimuli

  • Caitlin Farley

  • Carol Nanyunja

  • Christine Najuka

  • Cleophas Komugisha

  • Dan R Shelley

  • Edward A R Portal

  • Ellie Duckworth

  • Emilie Karafillakis

  • Geraldine O’Hara

  • Godfrey Matovu

  • Hannah G Davies

  • Janet Seeley

  • Joseph Peacock

  • Juliet Nsimire Sendagala

  • Katie Cowie

  • Kirsty Le Doare

  • Konstantinos Karampatsas

  • Lauren Hookham

  • Madeleine Cochet

  • Margaret Sewegaba

  • Mary Kyohere

  • Maxensia Owor

  • Melanie Etti

  • Merryn Voysey

  • Moses Musooko

  • Musa Sekikubo

  • Owen B Spiller

  • Patience Atuhaire

  • Paul T Heath

  • Philippa Musoke

  • Phiona Nalubega

  • Pooja Ravji

  • Richard Katungye

  • Ritah Namugumya

  • Rosalin Parks

  • Rose Azuba

  • Sam Kipyeko

  • Simon Beach

  • Stephen Bentley

  • Tim Old

  • Tobius Mutabazi

  • Valerie Tusubira

  • Vicki Chalker

  • March 10, 2025

  • 0 min

Share

Objective:

To assess neurodevelopmental and growth outcomes at 24 months in infants who survived invasive GBS sepsis compared to a matched cohort of infants without GBS sepsis.

Key Findings:
  • Survivors of GBS sepsis had lower cognitive and language scores compared to the non-GBS cohort (p-values to be included).
  • 31% of GBS sepsis survivors exhibited moderate to severe neurodevelopmental impairment versus 8.5% in the comparison group.
  • 25% of GBS survivors were undernourished compared to 10% in the comparison group, with severe undernutrition noted in those with cerebral palsy.
Interpretation:

Survivors of GBS sepsis in Uganda are at a significantly higher risk for neurodevelopmental impairments and growth issues compared to their peers, indicating a need for long-term follow-up and support in healthcare policy.

Limitations:
  • Small sample size of GBS sepsis survivors (16) may limit generalizability and introduce selection bias.
  • Data primarily from a single urban setting may not reflect rural experiences.
Conclusion:

The study highlights the need for ongoing monitoring and support for GBS sepsis survivors to address potential neurodevelopmental and growth challenges.

Original Source(s)

Related Content